Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease

NCT07541391 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Multiple Myeloma

Interventions

BIOLOGICAL: PMCC-COE-KMA

Sponsor

Peter MacCallum Cancer Centre, Australia

Collaborators

[object Object]